Vecuronium Bromide for Injection Now Available from Fresenius Kabi

Wednesday, October 28, 2020

About Vecuronium Bromide for Injection

Vecuronium Bromide for Injection is a non-depolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation

Fresenius Kabi announced today it has introduced Vecuronium Bromide for Injection in the United States. The lyophilized product is available in two strengths: 10mg per vial1 and 20mg per vial2.

Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.

“The introduction of another neuromuscular blocker from Fresenius Kabi demonstrates our further commitment to supporting anesthesiologists and other health care professionals with a broad line of medicines used in operating rooms and throughout hospitals,” said John Ducker, president and chief executive officer of Fresenius Kabi USA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.